CD13 As a Potential Theranostic Target for Prostate-Specific Membrane Antigen-Negative Prostate Cancer and First-in-human Study of [18F]alf-Cd13-l1 PET/CT Imaging.
European Journal of Nuclear Medicine and Molecular Imaging（2025）
Key words
Prostatic neoplasms,Positron emission tomography computed tomography,FOLH1 protein,CD13 antigens,Clinical trial
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined